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Abstract
The Dlx and Msx homeodomain transcription factors play important roles in the control of limb development. The
combined disruption of Msx1 and Msx2, as well as that of Dlx5 and Dlx6, lead to limb patterning defects with anomalies in
digit number and shape. Msx1;Msx2 double mutants are characterized by the loss of derivatives of the anterior limb
mesoderm which is not observed in either of the simple mutants. Dlx5;Dlx6 double mutants exhibit hindlimb ectrodactyly.
While the morphogenetic action of Msx genes seems to involve the BMP molecules, the mode of action of Dlx genes still
remains elusive. Here, examining the limb phenotypes of combined Dlx and Msx mutants we reveal a new Dlx-Msx
regulatory loop directly involving BMPs. In Msx1;Dlx5;Dlx6 triple mutant mice (TKO), beside the expected ectrodactyly, we
also observe the hallmark morphological anomalies of Msx1;Msx2 double mutants suggesting an epistatic role of Dlx5 and
Dlx6 over Msx2. In Msx2;Dlx5;Dlx6 TKO mice we only observe an aggravation of the ectrodactyly defect without changes in
the number of the individual components of the limb. Using a combination of qPCR, ChIP and bioinformatic analyses, we
identify two Dlx/Msx regulatory pathways: 1) in the anterior limb mesoderm a non-cell autonomous Msx-Dlx regulatory loop
involves BMP molecules through the AER and 2) in AER cells and, at later stages, in the limb mesoderm the regulation of
Msx2 by Dlx5 and Dlx6 occurs also cell autonomously. These data bring new elements to decipher the complex AER-
mesoderm dialogue that takes place during limb development and provide clues to understanding the etiology of
congenital limb malformations.
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Introduction
The developing vertebrate limb is widely adopted as a model to
study cell-cell signaling, pattern formation and morphogenesis,
and has provided a wealth of knowledge of the function and
regulation of specific transcription factors and signaling molecules
[1,2,3]. The phenotype of a large set of mutant mice with limb
defects led to the identification of genes and regulatory pathways
essential for normal limb development. The spatio-temporal
organization of the complex network of signaling and transcrip-
tional regulations has been elucidated only in part. In brief, genes
and regulatory modules can be related to the activation/
maintenance/regression of three signaling systems: a) Sonic
hedgehog (SHH) and the Zone of Polarizing Activity (ZPA), for
the control of digit patterning along the antero-posterior axis
[4,5,6], b) Fibroblast Growth Factors (FGFs) and the Apical
Ectodermal Ridge (AER), for the control of proximo-distal growth
and for ZPA maintenance [7,8,9,10,11], and c) Lmx1B, in the
mesoderm, and Wnt7a and En-1, in the ectoderm, for dorso-
ventral specification [12,13,14,15,16]. The three signaling systems
are organized in precise time- and space-restricted manners, and
are integrated in self-regulatory modules that assure the acquisi-
tion or the correct digit complements, limb morphogenesis and
overall growth [4,17,18,19]. The signaling molecules of the Bone
Morphogenetic Protein (BMP) class have been proposed to link
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these three systems together [20,21,22,23,24,25], thus they are
regarded as key players in the coordination of limb patterning,
morphogenesis and growth along the three axes.
Proximo-distal limb development and digit extension is directly
controlled by the signaling activity of the AER via expression of
morphogens of the FGF family [7,8,10,26] and their regulation by
other signaling molecules such as SHH and BMP antagonists
[20,21,27,28]. In this scenario, the Dlx and Msx homeobox
transcription factors, expressed in the AER and the mesoderm of
the limb buds, play an important morphogenetic role, although
their functions and regulations are yet to be defined at the
molecular level. Dlx5;Dlx6 double knock-out (DKO) mice are
characterized by loss of the central digit(s) and/or fusion with the
lateral ones [29,30]; these mice constitute a model of the human
congenital defect ectrodactyly or Split Hand Foot Malformation
type I, a condition linked to genomic alterations encompassing the
DLX5;DLX6 region, and for which point mutations in the DNA-
binding domain of DLX5 have recently been found [31]. The
double inactivation of Msx1 and Msx2 genes results in moderate-
penetrance polydactyly of the forelimbs (FL) and oligodactyly of
the hindlimbs (HL) (loss of the anterior digits and part of the tibia
in the zeugopod) [32,33,34].
Studies on the cellular and molecular functions of Dlx and Msx
proteins during limb development have met with difficulties owing
to several reasons. First, none of the single knockout for Dlx5, Dlx6,
Msx1 or Msx2 shows evident limb defects
[29,32,35,36,37,38,39,40,41], suggesting some degree of function-
al redundancy. Second, members of the Dlx and Msx families are
expressed both in the AER and in restricted regions of the limb
mesoderm [42,43]. Third, in vitro the Dlx and Msx proteins
compete for the same DNA binding sites, form heterodimers via
their homeodomain and reciprocally inhibit their transcriptional
activities [44], due to the high degree of homology of their
homeodomains [37,43,45,46,47]. However, current literature
suggest that Dlx and Msx proteins have distinct functions: Msx1
and Msx2 are known to control cell proliferation and differenti-
ation in a variety of cell types [48,49,50,51], while Dlx genes are
implicated in the differentiation of specific cell lineages, such as
forebrain interneurons [52,53,54], olfactory receptor neurons [55],
osteoblasts [35,56], and the AER and ectoderm [29,30,57,58].
Notably, Dlx and Msx genes have been shown to cooperate only in
specific cases [59,60,61], but not at all sites where they are co-
expressed. However, Dlx5 has been shown to regulate Msx2
transcription in the AER, via homeodomain binding elements
present in the gene’s promoter [62,63].
We investigate possible interactions between Dlx5;Dlx6 and
Msx1 or Msx2 in limb development, by generating double and
triple Dlx;Msx compound mutant mice and analyzing their limb
phenotypes. The limb phenotype of Msx1;Dlx5;Dlx6 triple knock-
out (TKO) mice shows features of theMsx1;Msx2 DKO phenotype
[32], leading to the conclusion that Dlx5;Dlx6 control the
expression of Msx2, but not of Msx1. In contrast, the limb
phenotype of Msx2;Dlx5;Dlx6 TKO mice is consistent with a
severe aggravation of the ectrodactyly defect. We also re-examine
the spatio-temporal expression of Dlx and Msx genes in FLs and
HLs and observe that in the AER these genes are co-expressed
whereas in the anterior mesenchyme Msx expression precedes that
of Dlx, ruling out a direct regulation of Msx by Dlx in this territory.
Combining these findings with qPCR expression analyses on the
limb buds of different compound embryos, and with ChIP data,
we propose that two modes of regulation coexist during limb
development: 1) a direct transcriptional regulation of Msx2 by Dlx
proteins in the AER and, later on, in the limb mesoderm, and 2) a
Bmp2- and Bmp4-mediated non-cell autonomous regulatory loop
between the AER and the anterior limb mesoderm.
Materials and Methods
Mouse Strains and Breeding
All animal procedures were reviewed and approved by the
Ethical Committee of the University of Torino and University of
Genova, the Italian Ministry of Health and the French Ministe`re
de l’Enseignement supe´rieur et de la Recherche. No surgery or
other manipulation on adult animals was used in this study. All
efforts were made to minimize suffering. Generation and
genotyping of the Dlx5lacZ/+ (hereafter named Dlx5+/2);
Dlx5;Dlx6neo/+ (hereafter named Dlx5;Dlx6+/2); Msx1lacZ/+ and
Msx2lacZ/+ (hereafter named, respectively, Msx1+/2 and Msx2+/2)
have been previously reported [29,32,35,39]. These mutations
were maintained on a C57B6;DBA F1 mixed genetic background,
throughout. TKO embryos and newborn were obtained by
crossbreeding either the Msx1+/2 or the Msx2+/2 single hetero-
zygous parents with the Dlx5;Dlx6+/2 double heterozygous ones,
and then crossing the triple heterozygotes. Following mating, the
day of the vaginal plug was considered as embryonic age 0.5
(E0.5).
Skeletal Preparation and b-galactosidase Detection
Cartilage staining (with Alcian Blue) of E14.5 embryos as well as
bone and cartilage staining (with Alcian Blue and Alizarine Red) of
E18.5 embryos were carried out as previously described [35]. For
lacZ expression analysis E10.5 embryos were fixed for 15–30 min
in 2% paraformaldehyde in PBS, while E14.5 embryos were fixed
for 15–30 min in 4% PFA. X-gal staining was performed as
described [35]. For detection of b-gal on limb sections, E10.5 and
E11.5 FLs and HLs were fixed with 4% paraformadehyde for 8–
12 hrs at 4uC, washed in PBS, cryoprotected with 30% sucrose,
frozen at 270uC, sectioned (thickness 11 mm) and stained as
described [35].
Whole-mount RNA in situ Hybridization
For RNA:RNA whole-mount in situ hybridization (WMISH),
embryos at the desired age were dissected in cold RNAse-free PBS,
fixed in cold 4% PFA for 12–16 hrs, rinsed with PBS,
permeabilized by treatment with proteinase-K, prehybridized
and hybridized as previously published [60]. Digoxygenin (DIG)-
UTP (Roche)-labeled antisense RNA probes were used, synthe-
sized by in vitro transcription with conventional methods.
WMISH was carried out following described procedures [64],
the signal was detected using an alkaline phosphatase-conjugated
anti-DIG antibody and developed with the chromogenic mix
NBT-BCIP (Roche). With each probe, at least two normal and
two mutant specimens were examined. The Dlx5 probe comprised
780 bp and was linearized with EcoRI and transcribed with T7
RNA polymerase [57]. The Dlx6 probe is a 350 bp fragment
spanning exons 3–4 [53]. The Msx1 probe was a 550 bp 39
spanning the homeodomain, containing exon 1; the Msx2 probe
corresponded to 378 bp in the first exon of Msx2 cDNA, the Fgf8
probe corresponded to most of the mouse coding sequence, the
Bmp4 probe (a kind gift from B. Hogan) contains the 39 UTR and
most of the coding sequence from a mouse cDNA [65], the probe
for Gremlin corresponded to the entire murine coding sequence (a
kind gift from R. Zeller). After hybridization, the signal was
revealed with the NBT-BCIP chromogenic reaction.
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RNA Quantification by Real-time PCR
Embryonic FLs and HLs at the age E11 were dissected in cold
RNase-free PBS, the anterior and posterior halves were separated
and pooled in RNA-later (Ambion). Pools of two half limbs from
the same embryos were used to extract total RNA, using the
Tissue Lyser II reagent followed by elution through RNA micro-
kit plus (Qiagen). cDNA synthesis was done using standard
conditions, 3 ng of each cDNA sample were used to carry out
qPCRs on a CFX96 equipment (Biorad) using the SybrSafe system
(Invitrogen). Samples were analyzed in technical triplicates, and
for each genotypes (except for the Msx1+/2;Dlx52/2;Dlx62/2)
biological triplicates could be analyzed. Primer sequences were
designed with the Primer Express online tool. RNA quality, primer
efficiency and correct size were tested by RT-PCR and agarose gel
electrophoresis. Standard curve were performed using WT cDNA
with four calibration points: 1:10; 1:40; 1:160; 1:640. Specificity
and absence of primer dimers was controlled by denaturation
curves. Rps9 mRNA abundance was used for normalization
(primer sequences provided in Table S1).
Genome-wide Identification of Dlx Binding Sites and
Target Genes
We used the Position-Weight matrix (PWM) provided by
JASPAR under accession PH0024.1. The score of a site was
computed with standard log-likelihood ratios, using as null model
the nucleotide frequencies computed over the whole intergenic
fraction of the mouse genome. We considered for further analysis
putative sites scoring 50% of the maximum possible score or
better. We selected among the sites identified above the ones that
are conserved in at least two of 8 vertebrate species (genome
sequence version in parenthesis): mouse (mm9), human (hg19),
cow (bosTau4), opossum (monDom5), platypus (ornAna1), chicken
(galGal3), frog (xenTro2), zebrafish (danRer6) and lamprey
(petMar1). A site is defined as conserved with species S if it lies
in a region of the mouse genome which is aligned with a region of
the S genome and the aligned sequence in/S/is a site according to
the same definition used for mouse sites. All genomic sequences
and pre-computed ‘‘Net’’ alignments were obtained from UCSC.
A ranked list of putative Dlx target genes was obtained from the
sites determined above by associating each site conserved in at
least one species to its closest Refseq mRNA, and then selecting
the sites located either within 10 kb upstream of the TSS, or
within the non-coding portion of the first exon, or in the first
intron. We then associated to each putative target a score equal to
the sum of the conservation scores (number of species) of its
associated sites.
Chromatin Immunoprecipitation
A DLX5-myc expression vectors (OriGene, USA) containing the
full-length human DLX5 cDNA with an in-frame insertion of the
myc-TAG at the C-terminus, was used as described [66]. The
Q178P point mutation [31] was inserted in the DLX5-myc
expression vector indicated above, by site directed mutagenesis
and sequence verified (Bio-Fab Research, Rome).
The U2Os human osteosarcoma cells were used; these cells
express low or undetectable levels of DLX5 mRNA endogenously,
but have been shown to respond to Dlx expression with activation
of the p63 promoter [57]. Eight mg of the DLX5-myc expression
vectors were used for transfections, which yielded an efficiency of
35% (number of myc-positive cells over total counted nuclei).
Chromatin was crosslinked, sonicated, immunoprecipitated with
either the anti-myc TAG (A-14 sc-789, SantaCruz, USA) or the
anti-acetyl-Histone H4 (06-866, ChIP Grade, Upstate Biotech-
nology USA,) antibodies and de-crosslinked according to instruc-
tions (EZ Magna ChipG, Millipore). Fragments of the human
BMP2 and BMP4 loci spanning the identified conserved regions
were PCR-amplified and analysed by gel electrophoresis (sequenc-
es provided in Table S2). Total chromatin was used as positive
control (input), chromatin from cells transfected with an empty
vector was used as negative control.
Results
Msx and Dlx Coexpression Analyses, in silico
Previous evidences indicate that Dlx5 binds to homeodomain-
responsive elements in a proximal region of the Msx2 promoter,
and thereby regulates its transcription [62,63]. To further support
this possibility, we have used a human-mouse co-expression
network, generated using published profiling datasets [67,68] and
found that DLX5 and MSX genes are connected, i.e. each ranks in
the first 1% of the co-expression lists of the other (p,0.01, data
not shown).
Next, we screened conserved regions of the vertebrate genome
for the presence of consensus Dlx DNA-binding sites, as defined by
the Dlx5 PWM [69] present in the Jaspar database (accession Nu
PH0024.1) [70] and reported in Table S3. As the PWM for Dlx5
reported in Jaspar is not highly informative, it is not surprising that
a total 565,995 putative binding sites were initially identified in the
mouse genome. However, by introducing evolutionary conserva-
tion with at least two (out of 8) species examined as a further
criteria, this number is reduced to 11,262 sites, and with
conservation in three species is further reduced to 4085 (Table
S3, complete lists available upon request). The full annotation on
the UCSC genome browser is available upon request. As positive
controls, the well defined Dlx sites present in the Dlx5;Dlx6
intergenic region [71] and in the Msx2 promoter [62,63] were
correctly predicted (Fig. S1). The evolutionary conservation of the
sites suggests the presence of positive selection pressure to maintain
the sites, confirming their functional relevance.
We then generated a ranked list of putative Dlx targets, based
on the position of predicted conserved Dlx sites in the genome, as
indicated in the Methods sections. The ranked list contains 3,051
Refseq mRNAs associated to 2,412 unique Entrez gene IDs
(available upon request). The Msx1 and Msx2 genes were found in
the top 10% of the list of putative Dlx targets, strengthening the
possibility that Dlx proteins might directly regulate Msx expres-
sion.
Expression of Msx and Dlx Genes during Limb
Development
We examined expression of Dlx5, Dlx6, Msx1 and Msx2 in the
FL and HL of normal embryos, at E10.5 and E11.5, by X-gal
staining of heterozygous embryos carrying an allele with inserted
lacZ reporter (Dlx5, Msx1, Msx2), and by WMISH (Dlx6) (Fig. 1).
WMISH for Dlx5, Msx1 and Msx2 have been previously reported
with comparable results. In the AER, all four genes are co-
expressed starting at E9.5/E10. On the contrary, in the limb
mesoderm they are expressed with a different time-of-onset. At
E10.5 Msx1 and Msx2 are mainly expressed in two mesoderm
territories (anterior and posterior) of both the FL and the HL
(Fig. 1E–H, S–V), whereas at the same stage the Dlx5 transcript is
detected only in the anterior mesoderm of the FL, and not that of
the HL (compare Fig. 1A–B with O–P). The Dlx6 transcript is not
detected in the mesoderm at this stage (Fig. 1C–D, Q–R). In the
HLs, mesodermal expression of Dlx5 starts around E11.5 and is
confined to the anterior margin (Fig. 1W–X). At this stage, Msx1
and Msx2 are expressed in the AER and in a larger region
Dlx and Msx Gene during Limb Development
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underneath the AER (Fig. 1K–N, Y-AB). Histological sections of
X-gal stained limb buds from Dlx5+/2, Msx1+/2 and Msx2+/2
embryos (Fig. 1W’, W’’, Y’ and AA’) reveal that Msx1 and Dlx5 are
truly co-expressed in the AER (strong signal in W’ and W’’) and in
the anterior HL mesoderm (a weak signal is present in W’’,
indicated with black arrows).
In summary, Msx expression precedes that of Dlx in the HL
anterior mesoderm, consequently in this location Dlx genes are
unlikely to regulate Msx gene transcription cell-autonomously and
Dlx and Msx proteins are unlikely to interact in the anterior limb
mesoderm, at early stages.
Msx2 Expression is Downregulated in Dlx5;Dlx6 DKO
Limbs
To investigate interactions between the Dlx and the Msx genes
during limb development, we used animals DKO for Dlx5;Dlx6
and analyzed the expression of the Msx-lacZ reporter in this
genetic background. To do this, we compared the expression
patterns of the lacZ reporter between Msx1+/2 and Msx1+/
2;Dlx52/2;Dlx62/2 mice (Fig. 2A–H), and between Msx2+/2 and
Msx2+/2;Dlx52/2;Dlx62/2 mice (Fig. 2I–P). We observed a clear
reduction of Msx2 expression in the anterior mesoderm and AER
exclusively in the HLs, whereas neither expression of Msx1 in the
HLs nor expression of Msx1 and Msx2 in the FLs were significantly
changed (Fig. 2A–P). To further document the reduction of Msx2
expression in the AER of Dlx5;Dlx6 DKO limbs, we carried out
WMISH for Msx2 on cryostatic sections of Dlx5;Dlx6 DKO HLs,
at E11. Msx2 expression was strongly reduced or absent in the
AER and the underlying mesoderm of a central wedge of the
mutant limbs, as compared to the same region of normal limbs
(Fig. 2Q,R).
Since WMISH is not a quantitative method, we used
quantitative Real Time PCR (qRT-PCR) to quantify the
reduction of Msx2 mRNA on samples extracted from the HLs of
normal and Dlx5;Dlx6 DKO embryos, at E11.5. Limb buds were
divided in two halves on the proximo-distal axis, to determine gene
expression in the anterior and posterior mesoderm separately. In
such samples, the AER cells contributed minimally, while most of
the RNA derives from the mesenchyme. Msx2 mRNA abundance
was reduced by 60% in the anterior half, and by 50% in the
posterior half of Dlx5;Dlx6 DKO HLs from the same embryo, as
compared to WT. In the same samples, expression of Msx1 was
minimally or not changed (Fig. 2S). We then determined the
abundance of Msx and Dlx mRNAs in the anterior half of the HLs
of Msx12/2 and Msx22/2 (single homozygous) mutant embryos,
as compared to WT. In the Msx22/2 mutant the expression level
of Dlx5, Dlx6 and Msx1 was unchanged, whereas in the Msx12/2
mutant the expression levels of Dlx5, Dlx6 and Msx2 were reduced
by 65%, 40% and 15%, respectively. Moreover, in the posterior
half of the HLs from the Msx12/2 mutant we observed a
reduction of 40% in the abundance of Dlx5 and Msx2 mRNA,
whereas Dlx6 did not change (Fig. 2T,U).
Limb Phenotype of Msx2;Dlx5;Dlx6 Triple Mutants
To reveal possible functional interactions between the Dlx and
the Msx gene products during limb development, we generated
TKO mice with genotype Msx12/2;Dlx52/2;Dlx62/2 or Msx22/
2;Dlx52/2;Dlx62/2. TKO newborns were obtained at a frequen-
cy lower than expected, and all died shortly after birth, due to
severe craniofacial malformations and consequent breathing
impairment. Quadruple knock-out embryos were never obtained
in spite of several attempts.
We examined the limb skeleton in the TKO animals at two
ages: E14.5 (with Alcian-Blue) and E18.5/birth (with Alcian-Blue
and Alizarine-Red, which stain, respectively, cartilages and
mineralized bones). In Msx2;Dlx5;Dlx6 TKO animals, the HLs
were severely affected (Fig. 3G,H) whereas no evident alteration
was observed in the FLs (data not shown). The central digit was
always missing, rarely (,10%) the two central digits were missing,
while the remaining digits extended pairwise towards the opposite
(anterior-posterior) sides. Importantly, no loss of anterior digits or
of zeugopod elements was ever observed (Fig. 3G,H). The limb
phenotype observed in the Msx2;Dlx5;Dlx6 TKO mutant animals
is consistent with a significant aggravation of the ectrodactyly
phenotype seen in Dlx5;Dlx6 DKO [29,30] (compare Fig. 3G with
3C, and 3H with 3D), without appearance of other recognizable
phenotypes. Remarkably a very similar phenotype, although less
severe, was observed in animals with genotype Msx2+/2;Dlx52/
2;Dlx62/2, i.e. in the presence of a single wild-type Msx2 allele
(Fig. 3E,F).
Limb Phenotype of Msx1;Dlx5;Dlx6 Triple Mutants
In Msx1;Dlx5;Dlx6 TKO mice the FL were usually normal,
although in one case (1/6) anterior polydactyly was observed (data
not shown). Of note, polydactyly has been reported for the FLs in
Msx1;Msx2 DKO mice with a moderate penetrance [32]. On the
contrary, the TKO HLs displayed a severe phenotype consisting
in the loss of the tibia and of 3–4 preaxial digits (Fig. 3I,J). Since
the HLs of Msx1;Msx2 DKO usually exhibit loss of 1–2 anterior
digits and of the tibia [32], we interpreted the TKO phenotype as
a combination of ectrodactyly, caused by the loss of Dlx5;Dlx6
[29,30] (Fig 3C,D), and the preaxial adactyly as observed upon the
loss of Msx1;Msx2 [32] (Fig. 3K).
The appearance of features of the Msx1;Msx2 DKO phenotype
in the Msx1;Dlx5;Dlx6 TKO animals, which retain two functional
Msx2 alleles, argues in favor of a severe reduction of Msx2
expression in the TKO limbs, as compared to the Dlx5;Dlx6 DKO.
Indeed, removing a single Msx1 allele in the context of
Dlx5;Dlx6 DKO background (i.e.Msx1+/2;Dlx52/2;Dlx62/2 em-
bryos) results in a 50% reduction of Msx2 mRNA in both the
anterior and the posterior half of the embryonic HLs, as compared
to WT. Moreover, expression ofMsx2 in the anterior and posterior
halves of Msx1 homozygus mutant HLs was reduced by 30%
compared to Msx1 heterozygous HLs (data not shown). This
indicates that reduced Msx2 expression may result from the
combination of (1) loss of Dlx5 and Dlx6 (Fig. 2U, Fig. S2),
upstream regulators of Msx2, and (2) the loss of Msx1, with the
consequent decrease of Msx2 expression (Fig. 2V).
Expression of Bmp4 and Gremlin in Dlx5;Dlx6 Mutant
Limbs
The phenotype of the Msx1;Dlx5;Dlx6 TKO HLs shares some
similarities with the Msx1;Msx2 DKO phenotype [32]. However,
defects in the anterior autopod and zeugopod cannot be simply
explained by a direct Dlx5;Dlx6 control on Msx2 expression, since
in the presumptive territory of the anterior zeugopod and autopod
the expression of Msx1 and Msx2 precedes that of Dlx5 and Dlx6
(Fig. 1). Therefore we hypothesized that a non-cell autonomous
regulation should take place, linking a defective AER with Msx2
misexpression in the anterior limb mesoderm. We focused on
Bmps as candidate signaling molecules since they are expressed in
the AER as well as the anterior and posterior mesoderm [21], and
since BMP signaling is known to induce Msx expression in several
embryonic territories [20,72].
We carried out WMISH for Bmp4 on Dlx5;Dlx6 DKO embryos
at E11 and found that expression is decreased specifically in the
central sector of the AER of the mutant HLs (3 of 4 embryos) but
not significantly in the anterior mesoderm (Fig. 4C,D). Bmp4
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Figure 1. Spatio-temporal expression of Dlx-Msx in developing limbs. A-N, forelimbs. O-AB, hindlimbs, at E10.5 (A-H, O-V) and E11.5 (I-N, W-
AB). Whole-mount X-gal staining on FLs and HLs from Dlx5+/2, Msx1+/2 and Msx2+/2 (lacZ+) heterozygous embryos are shown. Expression of Dlx6 was
detected by WMISH on embryonic limbs at the same ages and shown. At E10.5 Msx2 and Msx1 are expressed in the AER and the anterior and
posterior mesoderm of HLs and FLs. Dlx5 and Dlx6, at E10.5, are expressed in the AER of HLs and FLs and in the anterior limb mesoderm only of the
FLs, but not of the HLs. At later stages (E11.5), Dlx5 and Dlx6 are then expressed in the anterior mesoderm of HLs. Black arrows indicate mesodermal
expression. The AER is also indicated. Black asterisks indicate absence of expression. W’,W’’ histologic transversal sections of E11.5 HLs from Dlx5+/2
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expression was not significantly changed in the FLs of the same
embryos (Fig. 4A,B), as expected considering the lack of any
morphological defects in the FLs. As a further control, Bmp4
expression was retained in the pharyngeal arches region (Fig. 4E,F).
We also examined the expression of Gremlin in the limbs of E10.5
embryos. Gremlin is a BMP antagonist that participates in a
regulatory loop between Shh in the posterior limb mesoderm and
FGF4 in the posterior AER, which maintains the AER and ZPA
and promotes digit patterning and limb outgrowth [17,73,74]. The
anterior-posterior patterning and expression level of Gremlin did
not significantly change in either the FLs or the HLs of Dlx5;Dlx6
DKO embryos (Fig. 4G–L). Thus, we concluded that the
inactivation of Dlx5 and Dlx6 does not lead to significant
alterations of limb antero-posterior patterning. Finally, the
expression of Bmp7 was not significantly changed (data not shown).
Bmp2 and Bmp4 Expression Levels are Synergistically
Reduced by Msx and Dlx Mutations
The WMISH results reported above suggest that Bmp4
expression is unchanged in the anterior mesoderm of the limbs;
however this technique is poorly quantitative and cannot reveal
minor changes in gene expression level. To further investigate the
mechanism that might induce and/or sustain Msx2 expression in
the anterior half of the HLs, we determined the relative
abundance of Bmp2 and Bmp4 mRNAs by qRT-PCR in the
anterior and posterior halves of the embryonic HLs (E11) with
different genotypes. Expression of Bmp2 is mainly decreased in the
anterior (about 50%), and minimally in the posterior half (20%) of
the HLs from Dlx5;Dlx6 DKO embryos (Fig. 4O). Bmp2 expression
is similarly reduced in Msx12/2 HLs. Bmp4 expression is
minimally or not affected in the Msx12/2 mutants, while in the
Dlx5;Dlx6 DKO Bmp4 expression is reduced of about 30% and
20%, respectively, in the anterior and in the posterior halves
(Fig. 4O). Of note, Bmp4 expression is also reduced in Msx22/2
embryonic HLs, less severely in the anterior (30%) than the
posterior half (50%) (data not shown). Strikingly we observed a
strong synergy between Msx1 and Dlx5;Dlx6 in controlling BMP
expression. When combined with the Dlx5;Dlx6 DKO mutation,
the loss of a single Msx1 allele was sufficient to reduce Bmp2 and
Bmp4 expression to levels lower than 10% of that of control
samples, both in the anterior and in the posterior halves of the
HLs. Considering that Msx2 is a known target of Bmp2 and Bmp4
in several tissues [72,75,76], this may explain how Msx2 expression
is reduced in the Msx1;Dlx5;Dlx6 TKO, and how this mutant
shows a limb phenotype with similarities to the Msx1;Msx2 DKO.
Finally, we determined the abundance of Fgf8 and Shh mRNAs
in HL samples from the relevant genotypes (Fig. S3). The
Abundance of Fgf8 mRNA was slightly reduced in the absence of
Dlx5 and Dlx6 (DKO samples), and was further drastically reduced
when one Msx1 allele was eliminated in the absence of Dlx5;Dlx6.
Similarly, the abundance Shh mRNA (in the posterior half of the
limb buds) was slightly reduced in the absence of Dlx5 and Dlx6,
and was further reduced when one Msx1 allele was simultaneously
eliminated. While reduced Fgf8 expression is not surprising [30],
reduced Shh expression is novel and may contribute to the altered
digit number and morphogenesis seen in theMsx1,Dlx5;Dlx6 TKO
embryos.
Dlx5 Binds to Conserved Sequences in the Proximity of
the Bmp2 and Bmp4 Loci
To search for possible direct regulations of the Bmp2 and Bmp4
loci by Dlx5, we first exploited the genome-wide predictions of
conserved Dlx sites, described above. In the proximity of the Bmp2
locus we identified three Dlx consensus binding sequences, named
B2-RE1, located 30 kb upstream of the transcription start site
(TSS), B2-RE2 and B2-RE3, located respectively 3.5 kb and 18 kb
downstream of the end of the Bmp2 transcript. All these Dlx
binding elements are conserved, although not identical, in at least
two vertebrate species, and fall within stretches of conserved
genomic sequence (Fig. 5A,B). The B2–R3 element was recog-
nized as conserved only between human and mouse, and contains
6 (of 16 bases) mismatches, in non-critical positions. In the
proximity of the Bmp4 locus we identified two Dlx consensus
sequences, named B4-RE1 and B4-RE2, located respectively
430 bp upstream of the TSS and within the second intron,
conserved in at least two mammalian species (Fig. 5A,B). Also
these predicted Dlx binding sites fall within stretches of conserved
genomic sequence (sequences and genomic locations provided in
Tables S4 and S5).
To demonstrate that the Dlx5 protein physically binds to these
putative responsive elements, we transfected a human DLX5-myc-
tag expression vector [66] and the same one modified to harbor
the disease-causing point mutation Q178P [31] in the U2Os
osteoblast cells (Fig. 5C). These cells were chosen since they are of
human origin, they express low endogenous level of DLX5, have
been shown to respond to Dlx5 expression by activation of the p63
and other promoters [57], are of osteoblastic origin (Dlx5 plays a
role in late osteoblast differentiation [35]), and are easily
transfected. The crosslinked chromatin was immunoprecipitated
with an anti-myc antibody, or with anti-acetylated Histone 4
(H4Ac) and subjected to PCR amplification with primers flanking
the predicted DLX sites in the human genome. With the exception
of the B2-RE3 element (not shown), all the other elements showed
an enrichment of PCR amplification products from chromatin of
DLX5-myc transfected cells, as compared to the chromatin from
cells transfected with the empty vector (Fig. 5D). The same
elements immunoprecipitated with anti-H4Ac, suggesting that in
these locations the chromatin is available for transcription
regulation. Interestingly, the Q178P mutant DLX5 protein did
not show any binding to these sequences, thus this disease-causing
mutation is associated with loss of DNA-binding activity on the
Bmp elements. As further controls, PCR amplification of two
sequences containing no identifiable homeodomain-binding se-
quences (BMP2 exon 3 and BMP4 exon 5), as well as an irrelevant
sequence (IL10) did not show any enrichment (not shown). These
results reinforce the notion that DLX proteins physically interact
with four (out of five) conserved elements close to the BMP2 and
the BMP4 loci, and might exert a direct transcription regulatory
activity, relevant for normal limb development.
Discussion
Dlx5, Dlx6, Msx1 and Msx2 genes encode homeodomain
transcription factors involved in limb development. The targeted
disruption of each of these genes, individually, does not lead to
embryos, stained with Xgal. Y’,AA’ histologic transversal sections of HLs from Msx1+/2 (Y’) and Msx2+/2 (AA’) embryos, to compare AER and
mesodermal expression between these genes. Section planes and position are reported with red lines (in W, Y and AA). The extent of the Msx1-
positive anterior and posterior mesoderm regions, based on the micrographs in AA’ and AC’, are indicated with dashed lines. A strong Dlx5-lacZ
signal is detected in the AER (W’ and W’’), a weak Dlx5-lacZ signal, overlapping with the Msx1-lacZ and the Msx2-lacZ signal, is detected in the anterior
mesoderm (W’’, indicated by black arrows).
doi:10.1371/journal.pone.0051700.g001
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Figure 2. Reduction of Msx2 expression in Dlx5/Dlx6 DKO HLs. A-P. Whole-mount X-gal staining to detect Msx1 and Msx2 expression in
Dlx5;Dlx6 DKO. In the FL (A-D,I-L) no changes of expression is observed whereas in the HL (E-H, M-P), Msx2 expression is reduced in the AER and in the
anterior limb mesoderm of the Dlx5;Dlx6 DKO HLs. Q,R. Sections of WT (Q) and Dlx5;Dlx6 DKO mutant HLs (R) hybridized in situ to detect Msx2,
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limb defects, however double Msx1/Msx2 [33,34] and Dlx5/Dlx6
[29,30] mutant mice present severe limb malformations indicating
that these genes participate in the control of digit number and
morphogenesis. The Dlx and Msx homeodomains show a high
degree of sequence similarity and similar DNA binding sequences
in vitro [43]. In spite of these similarities, there is no evidence
suggesting that these homeoproteins cooperate or interact, except
in two specific developmental processes: elevation and fusion of the
palatal shelves [60,61] and development of the frontal bone [59].
In this work, we shed light on direct and indirect interactions
between these two classes of homeodomain genes during limb
development.
Direct and Indirect Dlx-Msx Regulations during Limb Bud
Development
Although Msx2;Dlx5;Dlx6 TKO mice show an aggravation of
the ectrodactyly phenotype, as compared to Dlx5;Dlx6 DKO, they
do not present any obvious additional defect. Furthermore,
inactivation of either Dlx5;Dlx6 or Msx2 does not modify the level
of Msx1 expression, suggesting that the Msx2;Dlx5;Dlx6 TKO
showing a drastically reduced Msx2 signal in the AER and in the underlying mesoderm, but not in a proximal mesoderm territory. S-U. Quantification
of the expression of Dlx5, Dlx6, Msx1 and Msx2 mRNAs by qRT-PCR in HLs from Dlx5;Dlx6 DKO (S), Msx22/2 (T) and Msx12/2 (U), relative to WT. The
results show a reduction of 45% of Msx2 expression in the Dlx5;Dlx6 DKO HLs compared to WT, but not of Msx1. Dlx5 and Dlx6 expression is
downregulated in Msx1 KO HLs but not in Msx2 KO HLs. Expression of the knocked-out genes was also tested, as control, and always found to be
reduced to undetectable levels (not shown).
doi:10.1371/journal.pone.0051700.g002
Figure 3. Skeletal preparations of the HLs of single and combined Msx;Dlx mutant animals. Chondroskeletal preparation of the HLs of
E14.5 embryos (micrographs on the left) and full skeletal preparation on newborn animals (micrographs on the right), representing single and
combined Dlx;Msx mutant genotypes (indicated on the left). The HLs of Msx2+/2;Dlx5;Dlx6 DKO animals (E,F) display an aggravated ectrodactyly
phenotype compared to Dlx5;Dlx6 DKO ones (C,D), with fusion of the external digit (1with 2, 4 with 5) and hypoplasia of the central digit.
Msx2;Dlx5;Dlx6 TKO HLs (G,H) display a further aggravated ectrodactyly phenotype, with the external digits fused and extended towards the opposite
(anterior-posterior) sides, and a complete absence of the central digit. The limbs of Msx1+/2;Dlx5;Dlx6 DKO mice (not shown) show ectrodactyly
similar to that observed in Dlx5;Dlx6 DKO mice, whereas Msx1;Dlx5;Dlx6 TKO mice (I,J) show ectrodactyly and loss of skeletal elements deriving from
the anterior mesoderm of the autopod and zeugopod, a phenotype seen in Msx1;Msx2 DKO mutant embryos (K). The stylopod shows no evident
defects. The anterior-posterior orientation is shown. The numbers 1–5 indicate the digits (1 is the toe). Asterisks indicate hypoplasia or absence of
skeletal structures. The drawings on the left schematically illustrate the Dlx-related (red elements) and the Msx-related (purple elements) skeletal
defects, corresponding to the genotypes examined.
doi:10.1371/journal.pone.0051700.g003
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phenotype represents the exclusive contribution of the absence of
Msx2 in the Dlx5;Dlx6 mutant context. This leads us to conclude
that either Msx2 has a rather minor function in limb development,
or that its function is largely compensated by Msx1, in agreement
with the limited defects observed in Msx1+/2;Msx22/2 compound
mutant animals [32] (Y. Lallemand, unpublished). On the
contrary, Msx1;Dlx5;Dlx6 TKO mice display a limb defect which
can be interpreted as the sum of the limb anomalies found in the
Msx1;Msx2 DKO and in the Dlx5;Dlx6 DKO. These results
strongly suggest that the expression of Msx2 is suppressed in this
genetic context, and that therefore Dlx5;Dlx6 are genetically
upstream of Msx2.
We show that in Dlx5;Dlx6 DKO limbs Msx2 expression is
diminished in the central sector of the AER. As starting at E10.5
Figure 4. Expression of Bmp4 in Dlx5;Dlx6 DKO limbs. A-D. Detection of Bmp4 mRNA by WMISH on WT (left) and Dlx5;Dlx6 DKO mutant (right)
limbs, at E11. FLs are on the top, HLs are on the bottom. E,F. In situ detection of Bmp4 mRNA in the pharyngeal arches region of WT (left) and
Dlx5;Dlx6 DKO mutant (right), at E11, as a control for RNA preservation. G-L. Detection of Gremlin mRNA in FLs (G,H) and HLs (I-L) of WT (left) and
Dlx5;Dlx6 DKO mutant embryos (right), at E10.5. While Bmp4 expression in the anterior mesoderm of the FLs (A,B) or the HLs (C,D) is unchanged
(green arrowheads), expression in the central wedge of the AER of mutant embryos is diminished in the HLs, but not in the FLs (red arrows in D).
Gremlin expression is unchanged both in the FLs (G,H) and in the HLs (I-L) of Dlx mutant embryos (red arrowheads). Genotypes and probes are
reported on the top. The Anterior-Posterior (A-P) orientation is indicated. M,N. whole-mount photographs documenting the reduced size of mutant
embryos and justifying the slightly reduced size of the mutant limbs, often observed. O. Quantification of Bmp2 and Bmp4 mRNAs by qRT-PCR in the
anterior and posterior halves of HLs from embryos with the genotype indicated on the top of each graph, compared to WT.
doi:10.1371/journal.pone.0051700.g004
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Dlx and Msx genes are co-expressed in the AER, it is possible to
hypothesize that in this territory Dlx proteins bind directly on the
Msx2 promoter, as previously reported [62,63]. On the contrary,
in the anterior limb mesenchyme, the expression of Msx1 and
Msx2 precedes that of Dlx5 and Dlx6. This precludes the possibility
of a direct regulation of Msx genes by Dlx proteins. Nevertheless,
our qRT-PCR analyses show that Msx2 expression is reduced in
the anterior limb mesoderm of Dlx5;Dlx6 DKO limbs, implying
the existence of a non cell-autonomous mode of regulation
between the AER and the anterior limb mesoderm. It is possible,
therefore, that a diffusible protein, expressed by AER cells in a
Dlx-dependent fashion, is required to initiate and/or sustain Msx2
expression in the anterior limb mesoderm.
Bmps as Signaling Relays between Dlx and Msx
Msx genes are well documented downstream effectors of BMP
signaling in several developing structures [72,77,78,79,80,81,82].
Enhanced BMP signaling in the limb in mice deficient for the
BMP antagonist Gremlin, results in upregulation of both Msx1 and
Msx2 expression [73]. Conversely, blocking BMP signaling in the
limb ectoderm by ectopic expression of Noggin, another BMP
antagonist, results in decreased Msx2 expression [23]. In the chick
limb buds, expression of a constitutively-active BMP receptor, or
misexpression of Msx1, in the dorsal ectoderm, induces the
formation of ectopic AERs [20]. In addition, the combined
inactivation of Msx1 and Msx2 leads to a phenotype that mimics,
in some aspects, the loss of BMP signaling [32].
Noticeably, Msx genes are also upstream of Bmp4 in several
developmental systems. During tooth germ development, meso-
dermal Msx1 is needed for efficient Bmp4 expression
[83,84,85,86]. Palatal development, which is impaired in
Msx12/2 mice, can be rescued by a Bmp4-expressing transgene
[87]. In the limb itself, Msx genes are required in the mesoderm for
maintenance of Bmp4 expression [34]. Thus, BMP signaling is
both upstream and downstream of Msx genes, depending on the
context and the developing structure. The possibility that Bmp2
and Bmp4 participate in a Dlx-Msx signaling loop between the
limb bud AER and mesoderm is clearly in line with previously
identified roles of these molecules.
Therefore, Bmps represented likely candidates to mediate a non
cell-autonomous regulation between AER-expressed Dlx5;Dlx6
and mesodermal Msx2. Indeed, we find that Bmp2 and Bmp4
expression is significantly reduced in Dlx5;Dlx6 DKO hindlimbs, at
E11 when no evident defect is yet visible. Reduction for Bmp2 and
Bmp4 in the anterior part of the HL is too high (50 and 30%,
respectively) to be accounted for by the ectoderm alone, and rather
indicates a downregulation of these Bmps in the mesoderm, too.
This could mean that Bmps produced in the ectoderm activate
Figure 5. Binding of DLX5 on predicted conserved elements close to BMP2 and BMP4. A. Location of predicted conserved Dlx binding sites
in regions of the mammalian genome around the BMP2 (top) and BMP4 (bottom) loci. Sites are indicated with colour vertical bars, the chromosomal
position and coordinates are shown. The mammalian genomic conservation is reported on the bottom. With the exception of B2-RE3, all elements fall
within stretches of conserved sequences. B. Sequences and alignment of the predicted Dlx binding elements. The sequence corresponding to the
PWM is shown in red. Dashed lines indicate the degenerated part of the binding sequence. C. Western blot analysis to demonstrate expression of
DLX5-myc and DLX5-Q184P-myc proteins in U2Os cells. The molecular weight of the detected proteins is indicated on the left. D. ChIP analyses on
the predicted Dlx binding sites in the human U2Os cells, transfected with the DLX5-myc and DLX5-Q178P-myc expression vector, or with the control
empty vector. The input chromatin (positive control) is shown on the left, ChIP with or without anti-myc are shown in the mid panels. ChIP with and
without anti-H4Ac on the same elements are shown on the right.
doi:10.1371/journal.pone.0051700.g005
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Bmps also in the mesoderm, either directly or via Msx1. Indeed,
further inactivation of one Msx1 allele in the context of the loss of
Dlx5;Dlx6 nearly abolishes Bmp2 and Bmp4 expression, necessarily
implying both the ectoderm and the mesoderm (Fig. 4K). This
downregulation would explain a reduction in Msx2 expression in
the anterior mesenchyme in the Dlx5;Dlx6 mutant limbs, at the
same embryonic ages. The direct action of Dlx over Bmp is further
supported by our ChIP data which indicate that DLX5, but not its
mutated variant Q178P [31], binds to conserved regions near the
BMP2 and BMP4 loci. However formal evidence that DLX5
activates BMP2 and BMP4 transcription is still lacking, as no
suitable AER-related cell line is available for such experiments. It
would be of interest to further investigate whether MSX1 also
binds to the same conserved sequences in the BMP2 and BMP4
promoters.
Such a non cell-autonomous mode of regulation is strikingly
similar to that occurring during development of the palatal shelves
and the tooth primordia, both of which involve diffusion of Bmp
between adjacent epithelial/mesodermal cell layers [60,87], and in
the case of the tooth germ, an induction of Bmp4 expression in the
mesoderm by ectodermal Bmp4 via expression of the Bmp target
Msx1 [85,86].
The loss of mesenchymal Bmp2, 4 and 7 expression, on the other
side, has been shown to be required for osteogenic differentiation,
in a dose-dependent fashion and with Bmp molecules acting in a
partially redundant way [88]. In their work, the selective loss of
Bmp2 and Bmp4 in the limb mesenchyme affects zeugopod
development and skeletogenesis, and less severely the autopod.
On a similar note, another work [22] shows that the gradual
elimination of Bmp4 from the limb mesenchyme is required to
rescue the Grem12/2 phenotype and a normal digit organization,
implying a right amount of mesenchyme-derived Bmps is essential
for AER function and for autopod morphogenesis. In the
Msx1;Dlx5;Dlx6 TKO mutants we observe a quite severe autopod
defect (loss of digits) accompanied, however, by less severe
zeugopod defect. Thus, it appears that both AER- and mesen-
chyme-derived Bmps are involved in the Msx;Dlx defects. The
possibility that misexpression of AER-Bmps alone directly cause
the TKO defects is unlikely. Rather, in light of the well known self-
regulatory system of signalling loops comprising FGFs, SHH and
BMPs [22], and considering that we observe changes in the
expression levels of Fgf8 and Shh upon loss of Msx1, Dlx5 and Dlx6
genes, most likely the overall nature of the limb defects in TKO
mutant embryos is a quantitative misregulation of the ‘‘slow
module’’ of this loop. Dlx and Msx genes can be regarded as new
players in this complex regulation. Since Shh participates in the
‘‘slow module’’, a more critical role for it could be envisioned, as
suggested by resemblance of the phenotype of Msx1;Dlx5;Dlx6
TKO limbs with that exhibited by Shh KO embryos [89].
Figure 6. A dynamic model for Dlx-Msx-Bmp functional interactions during HL development. Schematic drawing to summarize our
results and illustrate our model of functional interaction between Dlx5;Dlx6, Msx1, Msx2, Bmp2 and Bmp4. On the top, a scheme of the limb bud, the
AER (in light blue color) and the mesoderm (in pink color) is reported. Below, the proposed dynamic model of gene regulations, shown for an Early
(E9.5–E10, on the left) and a Late (E10–E10.5, on the right) phases of HL development, using the same color code as above. The anterior mesenchyme
is framed with a dotted black box; the Ant-Post and Prox-Dist directions are shown. Bmp2 and Bmp4 are placed at the interface between the AER and
the Ant Mes, to indicate that these are diffusible signaling molecules.
doi:10.1371/journal.pone.0051700.g006
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In conclusion, we propose a model that involves a complex
epithelial-mesodermal dialogue between Dlx and Msx (Fig. 6),
entailing two distinct modes of regulation in the limb buds: a
direct, cell-autonomous, regulation intrinsic to AER cells, and an
indirect regulation between the AER cells and the anterior limb
mesoderm. We further provide data suggesting that Bmp2 and
Bmp4 mediate a non cell-autonomous control of Dlx over Msx,
establishing a dialogue between the AER and the anterior
mesoderm of the developing limb.
Genotypes, Morphotypes, Gene Dosage and Expression
Levels
When comparing the limb phenotypes of the genetic series
Dlx5;Dlx6 DKO vs.Msx2+/2;Dlx52/2;Dlx62/2 vs. Msx2;Dlx5;Dlx6
TKO (Fig. 3C–H), we observe a clear increase in severity of the
ectrodactyly defect. This interesting observation can be explained
by introducing the notion that Msx2 expression depends on allelic
dosage, and that a threshold level of Msx2 expression is critical to
drive normal morphogenesis.
The importance of allelic dosage, hence quantitative gene
expression, is increasingly being recognized, even when pheno-
types are not evident (see [88,90]). As a further example, we detect
a reduction of Msx2 mRNA level in the Msx2+/2 mice, in which
no evident phenotype can be seen. Our explanation, in this case, is
that reduced Msx2 expression alone is not sufficient to cause limb
malformations due to the presence of two functional Msx1 alleles.
Loss of one Msx2 allele in the context of Dlx5;Dlx6 DKO, instead,
aggravates the phenotype. We explain this by proposing that Msx2
expression is severely reduced, approaching that of the null
condition, due to the combination of a) the genetic inactivation of
one allele, and b) the lack of Dlx5;Dlx6 genes.
Likewise, in Msx1;Dlx5;Dlx6 TKO animals, Msx2 expression is
further reduced. A residual level is nonetheless observed; however,
this is not sufficient to compensate for the loss of Msx1. In
conclusion, allelic dosage and quantitative gene expression are
crucial factors to be considered in the interpretation of a series of
phenotypes, especially when related genes are involved.
Conclusions
In human, the DLX5 and DLX6 genes cause the SHFM-type-1
congenital malformation when lost or mutated, while the MSX1
and MSX2 genes cause cleft palate and tooth agenesis. By
crossbreeding mutant mouse strains, we show that the Dlx5;Dlx6
and Msx1;Msx2 genes cooperate for normal limb development and
morphogenesis. At least two modes of regulation have emerged,
one in which Dlx5;Dlx6 control expression of Msx2 cell-autono-
mously, the other in which the AER and the anterior mesenchyme
interact non cell-autonomously, entailing Bmps as signaling
molecules. We further show that the BMP2 and BMP4 loci
comprise Dlx5-binding elements, occupied by Dlx5. Thus, the
highly related homeodomain genes Dlx and Msx are two key
players of a novel set of molecular and histological interactions
during limb development.
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